William Degrado

Dr. DeGrado is a prominent researcher working in the area of chemical biology, biochemistry, and biophysics at the University of California, San Francisco medical school. Prior to his current position, he spent 10 years at the University of Pennsylvania and 15 years at DuPont and DuPont-Merck Pharmaceuticals, reaching the level of Senior Director of Medicinal Chemistry before moving to academics in 1996. Dr. DeGrado has earned numerous awards, including membership in the National Academy of Sciences, and the American Association for the Advancement of Science, and he has been an adjunct faculty member at Harvard University and Johns Hopkins Medical Schools. He is a recent President of the Protein Society, has served on the Editorial Boards of 19 scientific journals, and has authored over 200 publications and multiple issued U.S. patents. Dr. DeGrado is the founder of PolyMedix (PYMX.OB) as well as InfluMedix, and has been on the scientific advisory boards for Xencor, Sunesis, and ExSAR. He holds a Ph.D. in Chemistry from the University of Chicago, and B.S. from Kalamazoo College